Tirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort study

Hsu WH, Chan YE, Wu JY, et al.

Frontiers in pharmacology, 2026;17:1917340

Cutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review

Gupta AK, Teasell EM, Magalhães RF, et al.

Medical sciences (Basel, Switzerland), 2026;14(6)

Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective

Ahmad I, Azmi S, Albabtain MA, et al.

Pharmaceutics, 2026;18(10)

Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging Phase 3 Evidence

Mateescu DM, Capraru ID, Enache B, et al.

Pharmaceutics, 2026;18(10)

Real-World Effectiveness, Documented Adverse Events, and Treatment Adherence of Semaglutide and Liraglutide in Omani Patients: A Retrospective Observational Study

Al-Himali N, Al-Habsi H, Al Mushrafi A, et al.

Journal of clinical medicine, 2026;15(20)

Weight Regain After Discontinuation of GLP-1 and GIP/GLP-1 Receptor Agonists: A Systematic Review

Marchetti M, Campisano G, Paragliola RM, et al.

Metabolites, 2026;16(10)

The impact of semaglutide initiated six months after laparoscopic sleeve gastrectomy on long-term weight loss and metabolic outcomes: single-center preliminary study

Jeske P, Roleder J, Zastawna K, et al.

Surgical endoscopy, 2026

Values, preferences, and treatment burden for initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, tirzepatide, and finerenone in adults with type 2 diabetes: systematic review

González-Cruz DC, Garcia-Campa M, Moreno-Peña PJ, et al.

BMJ medicine, 2026;5(1):e002780

Development and validation of qualitative methods for the detection of GLP-1 receptor agonists in serum and dried blood spots by LC-HRMS/MS for doping control purposes

Borschel L, Thomas A, Studer D, et al.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2026;1285:125326

Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety

Poolton JT, Minett J, Kazmi A

Acta orthopaedica Belgica, 2026;92(3)

Real-World Anthropometric Outcomes, Safety, and Use Patterns of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Obesity and Glucose Metabolism Disorder: A Nationwide Multicentre Community Pharmacy Study

Vergniory-Trueba O, Treceño-Lobato C

Healthcare (Basel, Switzerland), 2026;14(19)

Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence

Jain A, Gallacher DM, Issa MA, et al.

International journal of molecular sciences, 2026;27(19)

GLP-1 receptor agonists and lymphedema: from weight loss to potential direct modulation of lymphatic function

Merzel Šabović EK, Janić M, Planinšek Ručigaj T

Frontiers in endocrinology, 2026;17:1980239

Efficacy and Safety of Chemically Synthesized Semaglutide Injection (HD1916) for the Treatment of Obesity: A Multicenter, Randomized, Phase III Trial

Gao L, Ma Y, Zhang Q, et al.

Diabetes, obesity & metabolism, 2026

GLP-1 Receptor Agonists Are Associated With Lower Early Revision Risk Compared to Bariatric Surgery Following Total Hip Arthroplasty: A Retrospective Cohort Study

Brahmbhatt S, Mathew A, Shoap S, et al.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2026;:15563316261492267

Case Report: Panic attacks after tirzepatide injection in two female patients with recurrent depressive disorder

Palm U, Backmund M, Himmerich H

Frontiers in drug safety and regulation, 2026;6:1880796

Liraglutide reduces lipid accumulation in human orbital fibroblasts in Graves’ orbitopathy

Shih CW, Shih SR, Wei YH, et al.

Frontiers in endocrinology, 2026;17:1914378

Correction to: Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology;28(10)

Medicaid’s GLP-1 Coverage Gap: A Familiar and Correctable Policy Failure

Ayyappan P, Balkrishnan R

Medical care, 2026

GLP-1 receptor agonists for obstructive sleep apnea: a meta-analysis of randomized controlled trials

Carvalhal G, Mora MMR, Peralta-Jiménez GA, et al.

Sleep & breathing = Schlaf & Atmung, 2026;30(5)